The Rbm38-p63 Feedback Loop is Critical for Tumor Suppression and Longevity

Overview

Journal Oncogene

Specialties Molecular Biology
Oncology

Date 2018 Mar 10

PMID 29520104

Citations 14

Authors

Yuqian Jiang

Enshun Xu

Jin Zhang

Mingyi Chen

Elsa Flores

Xinbin Chen

Affiliations

Soon will be listed here.

Abstract

The RNA-binding protein Rbm38 is a target of p63 tumor suppressor and can in-turn repress p63 expression via mRNA stability. Thus, Rbm38 and p63 form a negative feedback loop. To investigate the biological significance of the Rbm38-p63 loop in vivo, a cohort of WT, Rbm38, TAp63, and Rbm38;TAp63 mice were generated and monitored throughout their lifespan. While mice deficient in Rbm38 or TAp63 alone died mostly from spontaneous tumors, compound Rbm38;TAp63 mice had an extended lifespan along with reduced tumor incidence. We also found that loss-of-Rbm38 markedly decreased the percentage of liver steatosis in TAp63 mice. Moreover, we found that Rbm38 deficiency extends the lifespan of tumor-free TAp63 mice along with reduced expression of senescence-associated biomarkers. Consistent with this, Rbm38;TAp63 MEFs were resistant, whereas Rbm38 or TAp63 MEFs were prone, to cellular senescence. Importantly, we showed that the levels of inflammatory cytokines (IL17D and Tnfsf15) were significantly reduced by Rbm38 deficiency in senescence-resistant Rbm38;TAp63 mouse livers and MEFs. Together, our data suggest that Rbm38 and p63 function as intergenic suppressors in aging and tumorigenesis and that the Rbm38-p63 loop may be explored for enhancing longevity and cancer management.

Citing Articles

TAp63γ is the primary isoform of TP63 for tumor suppression but not development.

Chen X, Sun W, Kong X, Ming X, Zhang Y, Yan W Cell Death Discov. 2025; 11(1):51.

PMID: 39915463 PMC: 11802870. DOI: 10.1038/s41420-025-02326-x.

An RNA-immunoprecipitation via CRISPR/dCas13 reveals an interaction between the SARS-CoV-2 5'UTR RNA and the process of human lipid metabolism.

Shimizu Y, Bandaru S, Hara M, Young S, Sano T, Usami K Sci Rep. 2023; 13(1):10413.

PMID: 37369697 PMC: 10300121. DOI: 10.1038/s41598-023-36680-6.

RBM38 Reverses Sorafenib Resistance in Hepatocellular Carcinoma Cells by Combining and Promoting lncRNA-GAS5.

Gao X, Lu C, Liu Z, Lin Y, Huang J, Lu L Cancers (Basel). 2023; 15(11).

PMID: 37296859 PMC: 10252096. DOI: 10.3390/cancers15112897.

TRIM17-mediated ubiquitination and degradation of RBM38 promotes cisplatin resistance in non-small cell lung cancer.

Zhong T, Zhang J, Liu X, Li H Cell Oncol (Dordr). 2023; 46(5):1493-1507.

PMID: 37219768 DOI: 10.1007/s13402-023-00825-6.

AGO-RBP crosstalk on target mRNAs: Implications in miRNA-guided gene silencing and cancer.

Kakumani P Transl Oncol. 2022; 21:101434.

PMID: 35477066 PMC: 9136600. DOI: 10.1016/j.tranon.2022.101434.

References

Dohn M, Zhang S, Chen X . p63alpha and DeltaNp63alpha can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes. Oncogene. 2001; 20(25):3193-205. DOI: 10.1038/sj.onc.1204427. View

Coppe J, Desprez P, Krtolica A, Campisi J . The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol. 2010; 5:99-118. PMC: 4166495. DOI: 10.1146/annurev-pathol-121808-102144. View

Porteiro B, Fondevila M, C Delgado T, Iglesias C, Imbernon M, Iruzubieta P . Hepatic p63 regulates steatosis via IKKβ/ER stress. Nat Commun. 2017; 8:15111. PMC: 5424198. DOI: 10.1038/ncomms15111. View

Zhang J, Cho S, Chen X . RNPC1, an RNA-binding protein and a target of the p53 family, regulates p63 expression through mRNA stability. Proc Natl Acad Sci U S A. 2010; 107(21):9614-9. PMC: 2906842. DOI: 10.1073/pnas.0912594107. View

Yang A, McKeon F . P63 and P73: P53 mimics, menaces and more. Nat Rev Mol Cell Biol. 2001; 1(3):199-207. DOI: 10.1038/35043127. View

Mills A, Zheng B, Wang X, Vogel H, Roop D, Bradley A . p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature. 1999; 398(6729):708-13. DOI: 10.1038/19531. View

Qian Y, Zhang J, Yan B, Chen X . DEC1, a basic helix-loop-helix transcription factor and a novel target gene of the p53 family, mediates p53-dependent premature senescence. J Biol Chem. 2007; 283(5):2896-905. PMC: 4118587. DOI: 10.1074/jbc.M708624200. View

Coppe J, Patil C, Rodier F, Sun Y, Munoz D, Goldstein J . Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 2008; 6(12):2853-68. PMC: 2592359. DOI: 10.1371/journal.pbio.0060301. View

Itahana K, Campisi J, Dimri G . Methods to detect biomarkers of cellular senescence: the senescence-associated beta-galactosidase assay. Methods Mol Biol. 2007; 371:21-31. DOI: 10.1007/978-1-59745-361-5_3. View

10.

Pappu R, Ramirez-Carrozzi V, Sambandam A . The interleukin-17 cytokine family: critical players in host defence and inflammatory diseases. Immunology. 2011; 134(1):8-16. PMC: 3173690. DOI: 10.1111/j.1365-2567.2011.03465.x. View

11.

Chen X, Liu G, Zhu J, Jiang J, Nozell S, Willis A . Isolation and characterization of fourteen novel putative and nine known target genes of the p53 family. Cancer Biol Ther. 2003; 2(1):55-62. DOI: 10.4161/cbt.180. View

12.

Meylan F, Richard A, Siegel R . TL1A and DR3, a TNF family ligand-receptor pair that promotes lymphocyte costimulation, mucosal hyperplasia, and autoimmune inflammation. Immunol Rev. 2011; 244(1):188-96. PMC: 3882070. DOI: 10.1111/j.1600-065X.2011.01068.x. View

13.

Zhang J, Yan W, Chen X . p53 is required for nerve growth factor-mediated differentiation of PC12 cells via regulation of TrkA levels. Cell Death Differ. 2006; 13(12):2118-28. DOI: 10.1038/sj.cdd.4401972. View

14.

Collado M, Blasco M, Serrano M . Cellular senescence in cancer and aging. Cell. 2007; 130(2):223-33. DOI: 10.1016/j.cell.2007.07.003. View

15.

Campisi J . Cancer, aging and cellular senescence. In Vivo. 2000; 14(1):183-8. View

16.

Wen L, Zhuang L, Luo X, Wei P . TL1A-induced NF-kappaB activation and c-IAP2 production prevent DR3-mediated apoptosis in TF-1 cells. J Biol Chem. 2003; 278(40):39251-8. DOI: 10.1074/jbc.M305833200. View

17.

Yang A, Kaghad M, Wang Y, Gillett E, Fleming M, Dotsch V . p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell. 1998; 2(3):305-16. DOI: 10.1016/s1097-2765(00)80275-0. View

18.

Krishnamurthy J, Torrice C, Ramsey M, Kovalev G, Al-Regaiey K, Su L . Ink4a/Arf expression is a biomarker of aging. J Clin Invest. 2004; 114(9):1299-307. PMC: 524230. DOI: 10.1172/JCI22475. View

19.

Su X, Gi Y, Chakravarti D, Chan I, Zhang A, Xia X . TAp63 is a master transcriptional regulator of lipid and glucose metabolism. Cell Metab. 2012; 16(4):511-25. PMC: 3483083. DOI: 10.1016/j.cmet.2012.09.006. View

20.

Shu L, Yan W, Chen X . RNPC1, an RNA-binding protein and a target of the p53 family, is required for maintaining the stability of the basal and stress-induced p21 transcript. Genes Dev. 2006; 20(21):2961-72. PMC: 1620019. DOI: 10.1101/gad.1463306. View